Grainne Quinn's most recent trade in Perrigo Company plc was a trade of 6,210 Restricted Stock Units done . Disclosure was reported to the exchange on April 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 6,210 | 6,210 | - | - | Restricted Stock Units | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 2,249 | 2,249 | - | - | Restricted Stock Units | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.69 per share. | 06 Mar 2024 | 2,249 | 22,248 (0%) | 0% | 29.7 | 66,773 | Ordinary Shares |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.09 per share. | 06 Mar 2024 | 1,759 | 20,914 (0%) | 0% | 28.1 | 49,410 | Ordinary Shares |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 1,759 | 3,517 | - | - | Restricted Stock Units | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.69 per share. | 06 Mar 2024 | 1,170 | 21,078 (0%) | 0% | 29.7 | 34,737 | Ordinary Shares |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.09 per share. | 06 Mar 2024 | 915 | 19,999 (0%) | 0% | 28.1 | 25,702 | Ordinary Shares |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 05 Mar 2024 | 9,028 | 23,850 (0%) | 0% | 27.3 | 246,103 | Ordinary Shares |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.26 per share. | 05 Mar 2024 | 4,695 | 19,155 (0%) | 0% | 27.3 | 127,986 | Ordinary Shares |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.26 per share. | 05 Mar 2024 | 1,583 | 15,646 (0%) | 0% | 27.3 | 43,153 | Ordinary Shares |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 1,583 | 0 | - | - | Restricted Stock Units | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.26 per share. | 05 Mar 2024 | 824 | 14,822 (0%) | 0% | 27.3 | 22,462 | Ordinary Shares |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 06 Mar 2023 | 5,276 | 5,276 | - | - | Restricted Stock Units | ||
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 06 Mar 2023 | 2,250 | 15,233 (0%) | 0% | 37.7 | 84,848 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 06 Mar 2023 | 2,250 | 4,498 | - | - | Restricted Stock Units | ||
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 06 Mar 2023 | 1,170 | 14,063 (0%) | 0% | 37.7 | 44,121 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 03 Mar 2023 | 5,419 | 14,537 (0%) | 0% | 38.7 | 209,986 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 03 Mar 2023 | 2,818 | 11,719 (0%) | 0% | 38.8 | 109,198 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 03 Mar 2023 | 1,584 | 1,583 | - | - | Restricted Stock Units | ||
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 03 Mar 2023 | 1,584 | 13,807 (0%) | 0% | 38.8 | 61,380 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 03 Mar 2023 | 1,052 | 0 | - | - | Restricted Stock Units | ||
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 03 Mar 2023 | 1,052 | 12,771 (0%) | 0% | 38.8 | 40,765 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 03 Mar 2023 | 824 | 12,983 (0%) | 0% | 38.8 | 31,930 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 03 Mar 2023 | 548 | 12,223 (0%) | 0% | 38.8 | 21,235 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 16 Dec 2022 | 2,368 | 9,118 (0%) | 0% | 31.6 | 74,947 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 6,748 | 6,748 | - | - | Restricted Stock Units | ||
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 6,008 | 12,759 (0%) | 0% | 37.2 | 223,678 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 3,125 | 9,634 (0%) | 0% | 37.2 | 116,344 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 1,584 | 12,310 (0%) | 0% | 37.2 | 58,972 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 1,584 | 3,167 | - | - | Restricted Stock Units | ||
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 1,226 | 10,860 (0%) | 0% | 37.2 | 45,644 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 1,226 | 0 | - | - | Restricted Stock Units | ||
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 1,052 | 11,274 (0%) | 0% | 37.2 | 39,166 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 1,052 | 1,052 | - | - | Restricted Stock Units | ||
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 824 | 11,486 (0%) | 0% | 37.2 | 30,678 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 638 | 10,222 (0%) | 0% | 37.2 | 23,753 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 04 Mar 2022 | 548 | 10,726 (0%) | 0% | 37.2 | 20,402 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 05 Mar 2021 | 4,751 | 4,751 | - | - | Restricted Stock Units | ||
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 05 Mar 2021 | 2,082 | 6,741 (0%) | 0% | 41.8 | 87,069 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 05 Mar 2021 | 1,226 | 6,884 (0%) | 0% | 41.0 | 50,315 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 05 Mar 2021 | 1,083 | 5,658 (0%) | 0% | 41.8 | 45,291 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 05 Mar 2021 | 1,053 | 7,299 (0%) | 0% | 41.0 | 43,215 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 05 Mar 2021 | 638 | 6,246 (0%) | 0% | 41.0 | 26,184 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 05 Mar 2021 | 548 | 6,751 (0%) | 0% | 41.0 | 22,490 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 29 Jun 2020 | 262 | 4,796 (0%) | 0% | 54.6 | 14,295 | Ordinary Shares | |
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 29 Jun 2020 | 262 | 0 | - | - | Restricted Stock Units | ||
Perrigo Company plc | Grainne Quinn | EVP, Chief Medical Officer | 29 Jun 2020 | 137 | 4,659 (0%) | 0% | 54.6 | 7,475 | Ordinary Shares |